Kyverna Therapeutics, Inc. (KYTX)
7.27
-0.35
(-4.59%)
USD |
NASDAQ |
Feb 05, 16:00
7.12
-0.15
(-2.06%)
After-Hours: 20:00
Kyverna Therapeutics Market Cap : 318.40M for Feb. 5, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.830B |
| CorMedix, Inc. | 579.10M |
| Castle Biosciences, Inc. | 945.71M |
| Vistagen Therapeutics, Inc. | 19.95M |
| Ocugen, Inc. | 435.34M |
Market Cap Related Metrics
| PEG Ratio | -0.0921 |
| Price to Book Value | 2.096 |
| Price | 7.27 |
| Earnings Yield | -51.18% |
| PEGY Ratio | -0.0921 |